The place of heterologous antilymphocytic globulin in renal transplantation.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001208:Asia; D001315:Australia; D004285:Dogs; D006086:Graft vs Host Disease / Q000209:etiology; D006648:Histocompatibility; D006736:Horses; D006801:Humans; D007106:Immune Sera; D007074:Immunoglobulin G / Q000627:therapeutic use; D007075:Immunoglobulin M / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007239:Infections / Q000209:etiology; D016030:Kidney Transplantation; D008214:Lymphocytes; D014181:Transplantation Immunology; D014182:Transplantation, Autologous / Q000009:adverse effects; D014183:Transplantation, Heterologous; D014777:Virus Diseases / Q000209:etiology
D000961:Antilymphocyte Serum; D007106:Immune Sera; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents